CARE Ratings rating – Buy: Robust final quarter for the company

[ad_1]


Mkt share expected to grow; FY22/23e EPS up 10/12%; TP up to Rs 825; Buy retained

[ad_2]

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Polynion

Binance Prediction

Metamask

papamiaspizza.com